Skip to content
stoqly

Amphenol

APH NYSE Electronic Components Financials FY2016–FY2025

Amphenol's revenue rose 51.7% to $23.1 billion in fiscal 2025. Its operating margin was 25.4%, up from 20.7% a year earlier. Free cash flow was $4.4 billion, up 103.7%. It paid out $1.5 billion in dividends and buybacks, 34% of free cash flow. The diluted share count rose 1.1%.

Last close · Oct 23, 2026

$74.09

1.4%
Value it Compare
Revenue Total sales reported in the income statement.
$23.1B
51.7% vs prior year
Operating margin Operating income as a share of revenue.
25.4%
4.7 pts
Net income Profit after all expenses, interest and tax.
$4.3B
76.2%
Free cash flow Cash from operations minus capital spending.
$4.4B
103.7%
Return on capital After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
29.1%
8.2 pts
Market cap Last close times the latest diluted share count, so it is approximate.
$95.5B
Oct 23 close
P/E Last close divided by diluted earnings per share over the last four quarters.
18.6x
On $3.99 EPS (TTM)

About these figures. Share counts and per-share figures for earlier years are restated for stock splits (2-for-1 and 2-for-1), so every year is on today's share basis.

What Amphenol does

No business description yet.

Legal name
AMPHENOL CORPORATION
Fiscal year ends
December 31, 2025
Latest annual report
—
Accession · CIK
0001104659-26-013549
0000820313

Revenue and margins

Amphenol had $23.1B of revenue in fiscal 2025, up 51.7% on the year before.

Revenue
Revenue
Margins, % of revenue
Gross Operating Net FCF
Margins, % of revenue
Gross Operating Net FCF

Net income and earnings per share

From fiscal 2016 to 2025, diluted EPS grew 19.9% a year. Loss periods are shown in red.

Net income
Net income
Diluted EPS
Diluted EPS

Returns on capital

After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.

Return on capital, equity and assets (annual)
Return on capital Return on equity Return on assets

Cash flow

Free cash flow was $4.4B in fiscal 2025, 19.0% of revenue. Cash from operations minus capital spending.

Free cash flow
Free cash flow
Cash from operations vs capital spending
Cash from operations Capital spending
Cash from operations vs capital spending
Cash from operations Capital spending

Dividends, buybacks and share count

Amphenol returned $1.5B to shareholders in fiscal 2025, 34% of free cash flow. The diluted share count rose 1.1%.

Dividends and buybacks
Dividends Buybacks
Dividends and buybacks
Dividends Buybacks
Diluted shares outstanding (annual)

Value Amphenol yourself

Change the assumptions and see what they imply per share. These are models, not forecasts or price targets — the answer depends entirely on what you put in.

Discounted cash flow

Value per share

—

Adds net cash of −$4.1B and divides by 1,277.5M diluted shares. Ten years of cash flows plus a terminal value, discounted to today.

Earnings multiple

Value per share

—

Reference multiples: today 18.6x · peers 50.8x · sector 33.5x.

Balance sheet

Cash, debt and the ratios that show how comfortably Amphenol can carry it.

Cash vs debt (incl. leases)
Cash Debt
Fiscal year endFY21FY22FY23FY24FY25
Cash and short-term investments $1.2B$1.4B$1.7B$3.3B$11.4B
Debt incl. finance leases $4.8B$4.6B$4.3B$6.9B$15.5B
Net debt / EBITDA 1.4x1.1x0.9x1.0x0.6x
Debt / equity 0.8x0.7x0.5x0.7x1.2x
Interest coverage 18.2x20.1x18.4x14.6x16.0x
Current ratio 2.4x2.4x2.2x2.4x3.0x
Quick ratio 1.7x1.6x1.5x1.8x2.5x
Total assets $14.7B$15.3B$16.5B$21.4B$36.2B
Total liabilities $8.3B$8.2B$8.1B$11.6B$22.7B
Shareholders' equity $6.3B$7.0B$8.3B$9.8B$13.4B
Net debt (− = net cash) $3.6B$3.1B$2.7B$3.6B$4.1B

Insider trades

Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.

Bought, 12 months

$1.3M

1 insider

Sold, 12 months

$330M

5 insiders

Of sales under plans

0%

$0.0M

DateInsiderTradeSharesPriceValueFiling
Aug 5, 2026 David M SilvermanEVP, Human Resources Sold 120,000 $174.24 $20.9M Form 4
Aug 4, 2026 Craig A LampoEvp& CFO Sold 193,200 $167.31 $32.3M Form 4
Aug 3, 2026 Lance E D'AmicoEVP, Secretary & GenCounsel Sold 100,000 $161.91 $16.2M Form 4
Jul 31, 2026 Richard Adam NorwittPresident & CEO, Director Sold 686,104 $161.76 $111M Form 4
May 5, 2026 Richard Adam NorwittPresident & CEO, Director Sold 17,500 $143.21 $2.5M Form 4
May 4, 2026 Richard Adam NorwittPresident & CEO, Director Sold 52,203 $142.04 $7.4M Form 4
May 1, 2026 Richard Adam NorwittPresident & CEO, Director Sold 61,072 $143.90 $8.8M Form 4
Feb 18, 2026 Craig A LampoExecutive VP & CFO Sold 100,000 $149.98 $15.0M Form 4
Feb 18, 2026 Lance E D'AmicoSee Remarks Sold 50,000 $149.88 $7.5M Form 4
Feb 12, 2026 Richard Adam NorwittPresident & CEO, Director Sold 608,333 $147.25 $89.6M Form 4
Feb 5, 2026 Robert LivingstonDirector Bought 10,000 $128.51 $1.3M Form 4
Dec 2, 2025 Peter StraubPresident, ISS Division Sold 132,000 $141.84 $18.7M Form 4

Piotroski F-score

Nine pass/fail tests of profitability, funding and efficiency. 8–9 is strong, 0–2 weak.

TestFY23FY24FY25
Net income is positive ✓ ✓ ✓
Cash from operations is positive ✓ ✓ ✓
Return on assets rose ✕ ✓ ✓
Cash from operations exceeds net income ✓ ✓ ✓
Debt fell relative to assets ✓ ✕ ✕
Current ratio rose ✕ ✓ ✓
Share count didn't rise ✓ ✕ ✕
Gross margin rose ✓ ✓ ✓
Revenue rose relative to assets ✕ ✓ ✓
F-score 6 / 97 / 97 / 9
Accruals ratio −3.8%−2.1%−3.8%
Altman Z'' 4.764.685.04

Similar companies

Each company's latest fiscal year. Fiscal years end in different months, so periods don't line up exactly.

CompanyMarket capGrowthOp. marginFCF marginROICP/EF-score
Amphenol APH $95.5B 51.7% 25.4% 19.0% 29.1% 18.6x 7
Corning GLW $108.2B 19.1% 14.6% 9.0% 10.8% 56.5x 6 Compare →
Coherent COHR $40.9B 22.5% — −14.4% 9.1% 50.8x 7 Compare →
Belden BDC $4.1B 10.3% 11.6% 8.1% 13.3% 16.9x 8 Compare →
Littelfuse LFUS $8.9B 8.9% 1.6% 15.3% 0.7% — 6 Compare →

10 years of figures

US$ millions unless stated. Hover a ratio's name for its definition.

Download CSV
Fiscal yearFY16FY17FY18FY19FY20FY21FY22FY23FY24FY25
Income statement
Revenue $6.3B $7.0B $8.2B $8.2B $8.6B $10.9B $12.6B $12.6B $15.2B $23.1B
Gross profit $2.0B $2.3B $2.7B $2.6B $2.7B $3.4B $4.0B $4.1B $5.1B $8.5B
Research and development $166M $194M $221M $234M $261M $318M $324M $342M $453M $647M
Operating income $1.2B $1.4B $1.7B $1.6B $1.6B $2.1B $2.6B $2.6B $3.2B $5.9B
Interest expense $72.6M $92.3M $102M $118M $115M $116M $128M $140M $217M $368M
Pretax income $1.1B $1.4B $1.6B $1.5B $1.5B $2.0B $2.5B $2.5B $3.0B $5.6B
Income tax $309M $692M $372M $332M $313M $409M $551M $509M $570M $1.3B
Net income $823M $651M $1.2B $1.2B $1.2B $1.6B $1.9B $1.9B $2.4B $4.3B
Diluted EPS $0.65 $0.52 $0.96 $0.94 $0.98 $1.27 $1.53 $1.55 $1.92 $3.34
Diluted shares 1.26B 1.27B 1.25B 1.23B 1.23B 1.25B 1.24B 1.24B 1.26B 1.28B
Cash flow
Cash from operations $1.1B $1.1B $1.1B $1.5B $1.6B $1.5B $2.2B $2.5B $2.8B $5.4B
Capital expenditure $191M $227M $311M $295M $277M $360M $384M $373M $665M $997M
Free cash flow $887M $918M $802M $1.2B $1.3B $1.2B $1.8B $2.2B $2.1B $4.4B
Depreciation and amortization $217M $227M $300M $312M $308M $396M $393M $406M $573M $922M
Stock-based compensation $47.6M $49.7M $55.6M $63.0M $70.5M $83.0M $89.5M $99.0M $110M $135M
Acquisitions $1.3B $266M $159M $937M $50.4M $2.2B $288M $970M $2.2B $3.8B
Share buybacks $326M $618M $935M $602M $641M $662M $731M $585M $689M $665M
Dividends paid $173M $205M $254M $280M $298M $347M $477M $501M $595M $802M
Dividends and buybacks $499M $823M $1.2B $881M $939M $1.0B $1.2B $1.1B $1.3B $1.5B
Balance sheet
Cash and short-term investments $1.2B $1.8B $1.3B $909M $1.7B $1.2B $1.4B $1.7B $3.3B $11.4B
Total debt $3.0B $3.5B $3.6B $3.6B $3.9B $4.8B $4.6B $4.3B $6.9B $15.5B
Finance lease liabilities $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M
Current assets $3.6B $4.7B $4.6B $4.2B $5.5B $6.0B $6.5B $6.8B $9.7B $20.3B
Current liabilities $1.6B $1.6B $2.5B $2.1B $2.3B $2.4B $2.7B $3.2B $4.1B $6.8B
Inventory $929M $1.1B $1.2B $1.3B $1.5B $1.9B $2.1B $2.2B $2.5B $3.4B
Property and equipment, net $711M $817M $876M $999M $1.1B $1.2B $1.2B $1.3B $1.7B $2.3B
Total assets $8.5B $10.0B $10.0B $10.8B $12.3B $14.7B $15.3B $16.5B $21.4B $36.2B
Total liabilities $4.8B $6.0B $6.0B $6.2B $6.9B $8.3B $8.2B $8.1B $11.6B $22.7B
Shareholders' equity $3.7B $4.0B $4.0B $4.5B $5.4B $6.3B $7.0B $8.3B $9.8B $13.4B
Margins
Gross margin 32.5% 33.0% 32.4% 31.8% 31.0% 31.3% 31.9% 32.5% 33.8% 36.9%
Operating margin 19.2% 20.4% 20.6% 19.7% 19.1% 19.4% 20.5% 20.4% 20.7% 25.4%
EBITDA margin 22.6% 23.6% 24.2% 23.5% 22.6% 23.0% 23.6% 23.6% 24.5% 29.4%
Net margin 13.1% 9.3% 14.7% 14.0% 14.0% 14.6% 15.1% 15.4% 15.9% 18.5%
FCF margin 14.1% 13.1% 9.8% 14.7% 15.3% 10.9% 14.2% 17.2% 14.1% 19.0%
Returns
Return on capital 17.8% 12.5% 21.2% 18.5% 17.5% 19.1% 20.0% 19.1% 20.9% 29.1%
Return on capital employed 18.1% 18.7% 21.1% 19.9% 17.5% 18.9% 20.8% 19.7% 20.6% 25.1%
Return on equity 23.8% 17.0% 30.1% 27.0% 24.3% 27.2% 28.6% 25.1% 26.7% 36.8%
Return on assets 10.3% 7.0% 12.0% 11.1% 10.4% 11.8% 12.7% 12.1% 12.8% 14.8%
Growth
Revenue growth 12.9% 11.5% 17.0% 0.3% 4.5% 26.5% 16.1% −0.5% 21.3% 51.7%
Net income growth 7.8% −21.0% 85.2% −4.2% 4.2% 32.2% 19.6% 1.4% 25.7% 76.2%
EPS growth 8.3% −21.1% 86.9% −2.3% 4.3% 29.6% 20.5% 1.3% 23.9% 74.0%
FCF growth 3.3% 3.5% −12.6% 50.5% 8.9% −10.3% 51.8% 20.4% −0.3% 103.7%
Share count change −0.4% 0.4% −1.2% −1.5% −0.2% 1.7% −0.7% −0.1% 1.8% 1.1%
Financial health
Net debt / EBITDA 1.3x 1.1x 1.2x 1.4x 1.1x 1.4x 1.1x 0.9x 1.0x 0.6x
Debt / equity 0.8x 0.9x 0.9x 0.8x 0.7x 0.8x 0.7x 0.5x 0.7x 1.2x
Interest coverage 16.6x 15.5x 16.6x 13.8x 14.2x 18.2x 20.1x 18.4x 14.6x 16.0x
Current ratio 2.2x 3.0x 1.9x 2.0x 2.4x 2.4x 2.4x 2.2x 2.4x 3.0x
Quick ratio 1.6x 2.3x 1.4x 1.4x 1.8x 1.7x 1.6x 1.5x 1.8x 2.5x
Capital allocation
Capex / revenue 3.0% 3.2% 3.8% 3.6% 3.2% 3.3% 3.0% 3.0% 4.4% 4.3%
Stock comp / revenue 0.8% 0.7% 0.7% 0.8% 0.8% 0.8% 0.7% 0.8% 0.7% 0.6%
Payouts / FCF 56.2% 89.7% 148.2% 73.0% 71.4% 85.5% 67.5% 50.4% 59.8% 33.5%
Quality scores
Piotroski F-score 8.0 5.0 5.0 6.0 6.0 6.0 7.0 6.0 7.0 7.0
Altman Z'' 4.5 4.7 4.2 4.1 4.4 4.3 4.7 4.8 4.7 5.0
Accruals ratio −3.2% −5.3% 0.9% −3.3% −3.4% 0.4% −1.8% −3.8% −2.1% −3.8%

Source: SEC EDGAR XBRL filings (CIK 0000820313). Data updated October 10, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only — not investment advice. Check the original filings before relying on any figure.

↑ ↓ to move · ↵ to open